Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ansari

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
BMJ Open|January 25, 2022
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocolNicolas Waespe, Sven Strebel, Tiago Nava, et al.
Transplantation and Cellular Therapy|August 24, 2022
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical TrialAnne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, et al.
Eclinicalmedicine|February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solutionAllison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
Transplantation and Cellular Therapy|November 1, 2025
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental GroupCandelaria Deimundo Roura, Persis Amrolia, Marc Ansari, et al.
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
Cancer Medicine|October 9, 2023
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studiesFabiën N Belle, Christina Schindera, Marc Ansari, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2021
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantationSimona Jurkovic Mlakar, Satyanarayana Chakradhara Rao Uppugunduri, Tiago Nava, et al.
Oncotarget|June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismStefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
The Lancet. Child & Adolescent Health|June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trialChrista Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Blood Advances|September 22, 2023
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM studyPeter Bader, Ulrike Pötschger, Jean-Hugues Dalle, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
BMJ Open|January 25, 2022
Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocolNicolas Waespe, Sven Strebel, Tiago Nava, et al.
Transplantation and Cellular Therapy|August 24, 2022
Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical TrialAnne-Charlotte Teyssier, Gérard Michel, Charlotte Jubert, et al.
Eclinicalmedicine|February 22, 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solutionAllison F O'Neill, Angela Trobaugh-Lotrario, James I Geller, et al.
Transplantation and Cellular Therapy|November 1, 2025
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental GroupCandelaria Deimundo Roura, Persis Amrolia, Marc Ansari, et al.
Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.
Cancer Medicine|October 9, 2023
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studiesFabiën N Belle, Christina Schindera, Marc Ansari, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2021
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantationSimona Jurkovic Mlakar, Satyanarayana Chakradhara Rao Uppugunduri, Tiago Nava, et al.
Oncotarget|June 9, 2015
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanismStefano J Mandriota, Linda J Valentijn, Laurence Lesne, et al.
The Lancet. Child & Adolescent Health|June 5, 2020
39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trialChrista Koenig, Nicole Bodmer, Philipp K A Agyeman, et al.
Blood Advances|September 22, 2023
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM studyPeter Bader, Ulrike Pötschger, Jean-Hugues Dalle, et al.
Pageof 20